What pre-treatment findings on CT scan (if any) influence your concern for GI perforation risk with bevacizumab use in ovarian cancer patients?
How (if at all) does this change your counseling and willingness to add bevacizumab to a regimen?
1 Answer
Mednet Member
Gynecologic Oncology · Columbia University Medical Center
Answered on
This is really a two parts question. The first question would be, do you offer bevacizumab to all your ovarian cancer patients and the second question would be what patients would you not recommend bevacizumab because of concern for bowel perforation?
Join for free or sign in to see the full answer